Effects of Nurse-Led Interventions on Quality of Life and Self-Care Among Patients With Heart Failure: A Systematic Review.

Scand J Caring SciSep 1, 2026
Clinical ResearchCardiologyOpen access

Rozainah Mat Yusoff, Wan Ling Lee, Imran Zainal Abidin

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluated the impact of nurse-led interventions on quality of life (QOL) and self-care in patients with heart failure (HF). Analyzing 19 eligible studies, the review found that interventions combining educational and psychological components significantly improved self-care and QOL. The study highlights the importance of diverse delivery methods, including face-to-face education and follow-ups.

Key findings

  • Nurse-led interventions significantly improved self-care and QOL in heart failure patients.
  • Interventions included education, cognitive behavioral strategies, and emotional support.
  • Most effective interventions combined educational and psychological components.
  • Delivery methods included face-to-face interaction, verbal education, and written materials.

Why it matters

Improving self-care and quality of life in heart failure patients is crucial for reducing complications and rehospitalizations. Nurse-led interventions can play a vital role in achieving these outcomes, thereby enhancing patient management and overall health.

Source

PubMed · PMID 42578706Free full text on PubMed Central

Published in Scand J Caring Sci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.